Volume 19, Issue 4 (Iranian South Medical Journal 2016)
Iran South Med J 2016, 19(4): 736-772 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohebbi G, Amini Khoei Z, Nabipour I. The toxinology of stingrays. Iran South Med J 2016; 19 (4) :736-772
URL: http://ismj.bpums.ac.ir/article-1-824-en.html
URL: http://ismj.bpums.ac.ir/article-1-824-en.html
1- The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran , mohebbihsn@yahoo.com
2- The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
2- The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
Abstract: (7830 Views)
Background: Stingrays belong to Chondrichthyes class.They live in freshwaters and oceans all over the world. They have venomous spines next to the root of the tail. Their barbed stingers covered with secretory cells that cause a large number of serious human injuries. In this review, we evaluate the toxinology of these venomous animals.
Results: Some of inoculated venom symptoms included the immediate and intense pain, inflammation and skin necrosis, bleeding wounds, acute edema, salivation, nausea, vomiting, diarrhea, fever, headaches, muscle cramps, tremors, paralysis, dyspnea, cardiovascular collapse, local vasoconstriction, seizures, coma, and rarely death. The venom contains 5-HT, 5-nucleotidase, acetylcholine , phosphodiesterase, proteolytic enzymes against casein, gelatin, and fibrinogen, and several toxins such as cystatins, galectin, peroxiredoxin 6, orpotrin and porflan, and other peptids and proteins including alpha subunit haemoglobin, ganglioside GM2 activator, glutathione s-transferase µ, leukocyte elastase inhibitor, transaldolase, ATP synthase, nucleoside diphosphate kinase and type III intermediate filament. Galectin has a diverse functions including anticoagulant, procoagulant, platelet-modulating, myotoxic and haemagglutination activities. Cystatins are potent inhibitors of cysteine proteinases, including papain and the cathepsins. Hydrolysis of lipids through PLA2 activity is one of the most important functions of peroxiredoxin-6. Orpotrin and porflan have vasoconstrictive and inflammatory effects, respectively.
Conclusion: Stingray venoms have different toxins and bioactive molecules with diverse mechanisms of toxicities. A thorough understanding of the toxicities mechanisms and clinical manifestations of stingrays’ venoms will provide the ability to treat effectively and manage injuries with this animals by clinicians and toxinologists.
Type of Study: Review Systematic and Meta Analysis |
Subject:
Disorders of Systemic, Metabolic or Environmental Origin
Received: 2016/08/4 | Accepted: 2016/08/24 | Published: 2016/09/11
Received: 2016/08/4 | Accepted: 2016/08/24 | Published: 2016/09/11
References
1. Thompson JR, Springer S. Sharks, Rays, Skates, and Chimaeras. United States Department of the Interior Fish and Wildlife Service Bureau of Commercial Fisheries. Washington, D.C. 1961; 1-15.
2. Burk MP, Richter PA. Stingray injuries of the foot. Two case reports. J Am Podiatr Med Assoc 1990; 80(5): 260-2. [PubMed] [Google Scholar]
3. Christine O. U.S.V.I. Animal Fact Sheet #29 Fish Department of Planning Aand Natural Resources, Division of Fish and Wildlife. (Accessed June 30, 2016, at http://ufdcimages.uflib.ufl.edu/UF/00/09/34/46/00029/00029Fish.pdf.)
4. Russell FE, Panos TC, Kang LW, et al. Studies on mechanisms of death from stingray venom. A report of two fatal cases. Am J Med Sci 1958; 235(5): 566-84. [PubMed] [Google Scholar]
5. Diaz JH. The Evaluation, Management, and Prevention of Stingray Injuries in Travelers. J Travel Med 2008; 15(2): 102-9. [PubMed] [Google Scholar]
6. Cooper NK. Stonefish and stingrays-some notes on the injuries that they cause to man. J R Army Med Corps 1991; 137: 136-40. [PubMed] [Google Scholar]
7. Kizer KW, McKinney HE, Auerbach PS. Scorpaenidae envenomation. A five-year poison center experience. JAMA 1985; 253(6): 807-10. [PubMed] [Google Scholar]
8. Marinkelle CJ. Accidents by venomous animals in Colombia. Ind Med Surg 1966; 35(11): 988-92. [PubMed] [Google Scholar]
9. CSRL (2007). Canadian Shark Research Lab, Bedford Institute of Oceanography and Marine Fish Species at Risk Section, Northwest Atlantic Fisheries Center. Skatesandrays. (Accessed June 30, 2016, at http://www.marinebiodiversity.ca/skatesandrays/External%20Anatomy%20Overall.htm.)
10. Sisneros JA, Tricas TC. Ontogenetic changes in the response properties of the peripheral electrosensory system in the Atlantic stingray (Dasyatis sabina). Brain Behav Evol 2002; 59(3): 130-40. [PubMed] [Google Scholar]
11. HSW (2015). Skates and Rays. (Accesses July 5, 2016, at http://animals.howstuffworks.com/fish/skate-and-ray-info.htm.)
12. Snyderman M, Wiseman C. Guide to marine life: Caribbean, Bahamas, Florida. New York: Aqua Quest Publications, 1996; 265 . [Google Scholar]
13. Acott C, Meier J. Clinical toxicology of venomous stingray injuries. In: Meier J, White J, editors. Handbook of clinical toxicology of animal venoms and poisons. Boca Raton, Florida: CRC Press, 1995: 135-40. [Google Scholar]
14. Mebs D. Venomous and poisonous animals. A handbook for biologists, toxicologists and toxinologists, physicians and pharmacists. Boca Raton, Florida: CRC Press, 2002; 91-110. [Google Scholar]
15. Russell FE, Van Harreveld A. Cardiovascular effects of the venom of the round stingray, Urobatis halleri. Arch Int Physiol Biochim 1954; 62(30): 322-33. [PubMed]
16. Russell FE, Barrit WC, Fairchild MO. Electrocardiographic patterns evoked by venom of the stingray. Proc Soc Exp Biol Med 1957; 96(3): 634-5. [PubMed] [Google Scholar]
17. Russell FE, Fairchild MD, Michaelson J. Some properties of the venom of the stingray. Med Arts Sci 1958; 12(2): 78-86. [PubMed] [Google Scholar]
18. Russell FE. Stingray injuries: a review and discussion of their treatment. Am J Med Sci 1953; 226(6): 611-22. [PubMed] [Google Scholar]
19. Halstead BW, Bunker NC. Stingray attacks and their treatment. Am J Trop Med Hyg 1953; 2(1): 115-28. [PubMed] [Google Scholar]
20. Germain M, Smith KJ, Skelton H. The cutaneous cellular infiltrate to stingray envenomization contains increased TIA+ cells. Br J Dermatol 2000; 143: 1074-7. [PubMed] [Google Scholar]
21. Haddad V Jr, Neto DG, de Paula Neto JB, et al. Freshwater stingrays: study of epidemiologic, clinical and therapeutic aspects based on 84 envenomings in humans and some enzymatic activities of the venom. Toxicon 2004; 43(3): 287-94. [PubMed] [Google Scholar]
22. Haddad Jr HJ. Atlas de animais aquáticos perigosos do Brasil: guia médico de identificação e tratamento de acidentes. São Paulo: Roca, 2000, 123-8. [Google Scholar]
23. Baumann K, Casewell NR, Ali SA, et al. A ray of venom: Combined proteomic and transcriptomic investigation of fish venom composition using barb tissue from the blue-spotted stingray (Neotrygon kuhlii). J Proteom 2014; 109: 188-98. [PubMed] [Google Scholar]
24. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant, procoagulant, and platelet modulating activities. Toxicon 2005; 45(8): 1099-114. [PubMed] [Google Scholar]
25. Almkvist J, Karlsson A. Galectins as inflammatory mediators. Glycoconj J 2004; 19(7-9): 575-81. [PubMed] [Google Scholar]
26. Wood ZA, Schröder E, Robin Harris J, et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28(1): 32-40. [PubMed] [Google Scholar]
27. Manevich Y, Reddy KS, Shuvaeva T, et al. Structure and phospholipase function of peroxiredoxin 6: identification of the catalytic triad and its role in phospholipid substrate binding. J Lipid Res 2007; 48(10): 2306-18. [PubMed] [Google Scholar]
28. Manevich Y, Fisher AB. Fisher Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 2005; 38(11): 1422-32. [PubMed] [Google Scholar]
29. Ochieng J, Chaudhuri G. Cystatin superfamily. J Health Care Poor Underserved 2010; 21(1 Suppl): 51-70. [PubMed] [Google Scholar]
30. Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp 2003; (70): 179-99. [PubMed] [Google Scholar]
31. Brillard-Bourdet M, Nguyên V, Ferrer-di Martino M, et al. Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom. Biochem J 1998; 33(Pt 1): 239-44. [PubMed] [Google Scholar]
32. Chen J, Deng M, He Q, et al. Molecular diversity and evolution of cystine knot toxins of the tarantula Chilobrachys jingzhao. Cell Mol Life Sci 2008; 65(15): 2431-44. [PubMed] [Google Scholar]
33. Grunclová L, Horn M, Vancová M, et al. Two secreted cystatins of the soft tick ornithodoros moubata: differential expression pattern and inhibitory specificity. Biol Chem 2006; 387(12): 1635-44. [PubMed] [Google Scholar]
34. Ribeiro JM, Alarcon-Chaidez F, Francischetti IM, et al. An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem Mol Biol 2006; 36(2): 111-29. [PubMed] [Google Scholar]
35. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269(33): 21191-7. [PubMed] [Google Scholar]
36. Araujo MLG, Charvet-Almeida P, Almeida MP, et al. Freshwater stingrays (Potamotrygonidae): status, conservation and management challenges. AC Info Doc 2004; 20: 1-6. [Google Scholar]
37. Conceição K, Konno K, Melo RL, et al. Orpotrin: A novel vasoconstrictor peptide from the venom of the Brazilian Stingray Potamotrygon gr. orbignyi. Peptides 2006; 27(12): 3039-46. [PubMed] [Google Scholar]
38. Conceição K, Santos JM, Bruni FM, et al. Characterization of a new bioactive peptide from Potamotrygon gr. orbignyi freshwater stingray venom. Peptides 2009; 30(12): 2191-9. [PubMed] [Google Scholar]
39. Lameiras JL, da Costa OT, Moroni FT, et al. Systemic rhabdomyolysis induced by venom of freshwater stingrays Plesiotrygon iwamae and Potamotrygon motoro (Chondrichthyes-Potamotrygonidae) from the Amazon Basin. Toxicon 2014; 77: 105-13. [PubMed] [Google Scholar]
40. Masson AA, Ormonde do Carmo PHA, Carvalho JLV. Rhabdomyolysis secondary to an accident with marine stingray (Dasyatis family). J Venom Anim Toxins Inc Trop Dis 2012; 18(3): 344-8. [Google Scholar]
41. Church JE, Hodgson WC. The pharmacological activity of fish venoms. Toxicon 2002; 40(8): 1083-93. [PubMed] [Google Scholar]
42. Rodrigues RJ. Pharmacology of South American freshwater stingray venom (Potamotrygon motoro). Trans N Y Acad Sci 1972; 34(8): 677-86. [PubMed] [Google Scholar]
43. Barbaro KC, Lira MS, Malta MB, et al. Comparative study on extracts from the tissue covering the stingers of freshwater (Potamotrygon falkneri) and marine (Dasyatis guttata) stingrays. Toxicon 2007; 50(5): 676-87. [PubMed] [Google Scholar]
44. Antoniazzi MM, Benvenuti LA, Lira MS, et al. Histopathological changes induced by extracts from the tissue covering the stingers of Potamotrygon falkneri freshwater stingrays. Toxicon 2011; 57(2): 297-303. [PubMed] [Google Scholar]
45. Kestin M, Miller L, Littlejohn G, et al. The use of unproven remedies for rheumatoid arthritis in Australia. Med J Aust 1985; 143(11): 516-8. [PubMed] [Google Scholar]
46. Rejholec V. Long-term Studies of Anti-osteoarthritic Drugs: an Assessment. Semin Arthritis Rheum 1987; 17(2 Suppl 1): 35-53. [PubMed]
47. Ravitchandirane V, Yogamoorthi A. Studies on the analgesic and anti-inflammatory properties of crude extracts of sting ray, Dasyatis zugei (Muller and Henle 1841). Biosci Biotech Res Asia 2008; 5(1): 343-8. [Google Scholar]
48. Behzadi S. Study on diversity and distribution of Batoidfishes in Persian Gulf (Hormozgan Province). [dissertation]. Bandar Abbass: Azad University of Bandar Abbass, 2007. (Persian) [Google Scholar]
49. Dehghani H, Sajjadi MM, Parto P, et al. Histological characterization of the special venom secretory cells in the stinger of rays in the northern waters of Persian Gulf and Oman Sea. Toxicon 2010; 55(6): 1188-94. [PubMed] [Google Scholar]
50. Adams S. Bites and Stings, marine stings. Accident and Medical Practitioners Association, New Zealand, JAMPA 2007; 4(1): 1-10. http://rnzcuc.org.nz/Portals/0/Documents/Adams_Bites%20and%20Stings%20Marine%20stings%20FINAL.pdf.
51. Scharf MJ. Cutaneous injuries and envenomations from fish, sharks, and rays. Dermatol Ther 2002; 15(1): 47-57. [Google Scholar]
52. Garnier CR. Occupational injuries due to stingrays. Trans R Soc Trop Med Hygiene 1980; 74(3): 408. [PubMed]
53. Haines C. 2008. Stingray Injury Treatment. (Accessed June 30, 2016, http://www.eMedicineHealth.com.)
54. Nabipour I. The venomous animals of the Persian Gulf. Bushehr: Bushehr University of Medical Sciences Press 2012, 64-78 . (Persian) [Google Scholar]
55. Perkins RA, Morgan SS. Poisoning, Envenomation, and Trauma from Marine Creatures. Am Fam Physician 2004; 69(4): 886-90. [PubMed] [Google Scholar]
56. Isbister GK. Venomous fish stings in tropical northern Australia. Am J Emerg Med 2001; 19(7): 561-5. [PubMed] [Google Scholar]
57. Dehghani H, Sajjadi MM, Rajaian H, et al. Study of patient's injuries by stingrays, lethal activity determination and cardiac effects induced by Himantura gerrardi venom. Toxicon 2009; 54(6): 881-6. [PubMed] [Google Scholar]
58. Thomas C, Scott S. All stings considered: first aid and medical treatment of Hawai’i’s marine injuries. Honolulu: University of Hawai’i Press, 1997, 1-233. [Google Scholar]
59. Weiss BF, Wolfenden HD. Survivor of a stingray injury to the heart. Med J Aust 2001; 175(1): 33-4. [PubMed] [Google Scholar]
60. Fry BG, Roelants K, Champagne DE, et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 2009; 10: 483-511. [PubMed] [Google Scholar]
61. Casewell NR, Wüster W, Vonk FJ, et al. Complex cocktails: the evolutionary novelty of venoms. Trends Ecol Evol 2013; 28(4): 219-29. [PubMed] [Google Scholar]
62. Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008; 5(11): e218. [PubMed] [Google Scholar]
63. Garrone Neto D, Haddad Junior V. [Tingrays in rivers in southeastern Brazil: occurrence localities and impact on the population]. Rev Soc Bras Med Trop 2010; 43(1): 82-8. [PubMed] [Google Scholar]
64. Smith WL, Wheeler WC. Venom evolution widespread in fishes: a phylogenetic road map for the bioprospecting of piscine venoms. J Hered 2006; 97(3): 206-17. [PubMed] [Google Scholar]
65. Sivan G. Fish venom: pharmacological features and biological significance. Fish Fisheries 2009; 10(2): 159-72. [Google Scholar]
66. Hwang JH, Jung BM, Rha SJ, et al. Nutritional Composition Changes in Skate (Raja kenojei) during Different Ripening Periods. J Nutr Food Sci 2014; 4: 295. [Google Scholar]
67. Rathinambal V, Kavimani S, Ravitchandirane V. Evaluation of analgesic, anti-inflammatory and Anti-cancer Activities of Cartilage Extract of Aetobatus narinari. Int J Pure App Biosci 2014; 2(3): 331-7.
68. Halstead BW, Vicini MV. Venomous fish stings (ichthyoacanthotoxicoses). Clin Dermatol 1987; 5(3): 29-35. [PubMed] [Google Scholar]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
